Suggestions
Steve Hahn
Experienced CEO and Medical Executive
Steve Hahn is a prominent healthcare executive and former government official with extensive experience in oncology and medical research. He currently serves as the CEO of Harbinger Health and CEO-Partner at Flagship Pioneering.34
Professional Background
Dr. Hahn has had a distinguished career spanning various leadership roles:
- Current Positions: CEO of Harbinger Health and CEO-Partner at Flagship Pioneering since December 2021.3
- Government Service: Served as the 24th Commissioner of the U.S. Food and Drug Administration (FDA) from December 2019 to January 2021.12
- Academic Medicine: Prior to his FDA role, he held several high-ranking positions at MD Anderson Cancer Center, including Chief Medical Executive and Deputy President/Chief Operating Officer.12
- Research and Clinical Practice: Focused on radiation oncology, with leadership roles at the University of Pennsylvania's Perelman School of Medicine.12
Education and Training
Dr. Hahn's educational background includes:
- M.D. from Temple University School of Medicine.13
- B.A. in Biology from Rice University.13
- Residency in internal medicine at the University of California San Francisco.12
- Fellowship and residency at the National Cancer Institute in Bethesda, Maryland.12
Current Focus
At Harbinger Health, Dr. Hahn is working on pioneering the detection of early cancer through blood-based tests.4 The company aims to develop affordable and accessible early-stage cancer screening methods.5
Research and Publications
Throughout his career, Dr. Hahn has made significant contributions to medical research:
- Authored over 220 peer-reviewed original research articles.12
- Focused on tumor microenvironment, signal transduction pathways, and proton therapy.12
Dr. Hahn's diverse experience in healthcare leadership, oncology, and regulatory affairs has positioned him as a key figure in the development of innovative health technologies and cancer detection methods.
